GlassScriptPhysician profile
Joan Iacobelli
NPI 1144267121
$613.70
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.73 · 2020: $85.93 · 2021: $209 · 2022: $22.46 · 2023: $145 · 2024: $80.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $184.42 | 2020-2024 | Gore Acuseal Cardiovascular Patch Vascular, Gore Viabahn Vbx Balloon Expandable Endo |
| Ethicon US, LLC | $107.86 | 2019-2023 | Vistaseal, Stratafix |
| Smith+Nephew, INC. | $63.56 | 2023-2024 | Stravix, Grafix Pl |
| Terumo Medical Corporation | $29.51 | 2020 | |
| Bolton Medical INC | $28.65 | 2019 | |
| Karl Storz Endoscopy-America | $26.65 | 2021 | |
| Abbott Laboratories | $25.11 | 2021 | |
| Teleflex LLC | $24.52 | 2019 | |
| Medtronic, INC. | $23.48 | 2023 | Venaseal |
| Ethicon INC. | $22.37 | 2021 | |
| Heron Therapeutics, INC. | $20.43 | 2021 | |
| Cvrx, INC. | $20.39 | 2023 | Barostim Neo System |
| Davol INC. | $20.12 | 2021 | |
| Merit Medical Systems INC | $16.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Iacobelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.